What's new

Human medicines European public assessment report (EPAR): Silodosin Recordati, silodosin, Date of authorisation: 07/01/2019, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Silodosin Recordati, silodosin, Date of authorisation: 07/01/2019, Revision: 3, Status: Authorised

Mar 10, 2025 - 17:59
 0
Human medicines European public assessment report (EPAR): Silodosin Recordati, silodosin, Date of authorisation: 07/01/2019, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Silodosin Recordati, silodosin, Date of authorisation: 07/01/2019, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

Wayve demonstrates generalizable AI driving in the US, marking a major milestone...

Next Article

How to build a beverage brand: Bodyarmor on shaking up the sports drinks category

Related Posts

European Medicines Agency post-authorisation procedural...

Feb 18, 2025  0

Human medicines European public assessment report (EPAR): Imjudo, tremelimumab, Date of authorisation: 20/02/2023, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 18, 2025  0

Human medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0